MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells	https://doi.org/10.18632/oncotarget.3025	2015	Cell line 10 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN	https://doi.org/10.1007/s13277-013-1274-1	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-211-5p promotes the apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11	https://doi.org/10.1139/bcb-2018-0380	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration	https://doi.org/10.1016/j.bbrc.2014.02.007	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin	https://doi.org/10.1016/j.bbrc.2018.02.091	2018	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16	https://doi.org/https://doi.org/10.1159/000438575	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.	https://doi.org/10.1097/FPC.0000000000000245	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 4 Master/Detail View	Clinical 0 Master/Detail View
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.	https://doi.org/10.1097/FPC.0000000000000291	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 1 Master/Detail View	Clinical 0 Master/Detail View
Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia	https://doi.org/10.1371/journal.pone.0091261	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.	https://doi.org/10.1038/s41397-017-0003-3	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 2 Master/Detail View	Clinical 0 Master/Detail View
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity.	https://doi.org/10.2217/epi-2017-0138	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 1 Master/Detail View	Clinical 0 Master/Detail View
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis	https://doi.org/10.1007/s00381-008-0701-x	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 13 Master/Detail View
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways	https://doi.org/10.1371/journal.pone.0056334	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis	https://doi.org/10.1038/leu.2017.73	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia	https://doi.org/10.1038/leu.2013.49	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases	https://doi.org/10.22034/APJCP.2018.19.8.2263	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors.	https://doi.org/10.1186/s12885-019-5739-5	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia.	https://doi.org/ 10.1016/j.cancergen.2016.09.009	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children.	https://doi.org/10.3109/10428194.2015.1092528	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastoma	https://doi.org/10.3233/cbm-160248	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View

Publications